October 2017

25 Sep
01Oct

2017-09-25 - 2017-10-01

European Biotech Week 2017

Europe

The European Biotech Week celebrates biotechnology, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech Week that took place in 2013 marked the 60th anniversary of this pivotal moment in history.

more…

10
11Oct

2017-10-10 - 2017-10-11

European Business Development Conference, 2017

Heidelberg

The EBDC is a two-day meeting that aims to bring a selected group of 120 business development executives from international pharmaceutical corporations and European biotech companies together with representatives from private equity and venture capital companies.

more…

10 Oct

2017-10-10 · 09:00

Webinar: Venture Capital Funding - An Insider’s View (I)

Our Life Science business is fully dedicated to supporting small, biotech companies with cutting edge technologies. Besides technical aspects of molecule development and production, fundraising is omnipresent. This webinar will provide insights and perspectives from Merck Ventures, BV, a subsidiary of Merck KGaA, Darmstadt, Germany.

more…

17
18Oct

2017-10-17 - 2017-10-18

bionection

Central-Germany

The aim behind the annual two-day bionection conference is to showcase transferable projects rooted in research excellence as well as technology offers and requests in order to attract potential business partners.

more…

24 Oct

2017-10-24

Road to the Clinic for Biologic Therapeutics

Leiden

Johnson & Johnson Innovation, JLABS and Janssen BioTherapeutics invite you to an in-depth look into the process of filing biologic Clinical Trial Authorisation (CTA) applications and the procedures necessary for advancing your company's early-stage drug development program.

more…

25 Oct

2017-10-25

Road to the Clinic for Biologic Therapeutics

Munich

Johnson & Johnson Innovation, JLABS and Janssen BioTherapeutics invite you to an in-depth look into the process of filing biologic Clinical Trial Authorisation (CTA) applications and the procedures necessary for advancing your company's early-stage drug development program.

more…